Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Stemirna Therapeutics logo — company profile

Stemirna Therapeutics

Founded 2016 4 employees Series D Total: $1.33B Biotechnology, Pharmaceutical

General Information

Company Name Stemirna Therapeutics
Founded Year 2016
Employees 4
Industries Biotechnology, Pharmaceutical
Funding Stage Series D
Social

Get notified when Stemirna Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Stemirna Therapeutics

Stemirna Therapeutics is a biotechnology and pharmaceutical startup founded in 2016. The company specializes in RNA technology for drug development, with a focus on leveraging the full potential of RNA science. Stemirna Therapeutics boasts a portfolio of over a dozen independently-developed mRNA drug projects, targeting areas such as mRNA-based personalized cancer vaccines, mRNA vaccines for infectious diseases, treatments for protein defect diseases, and genetic disorders. Their primary mission is to offer solutions for cancer and infectious diseases, ultimately aiming to enhance patient care. The most recent funding milestone for Stemirna Therapeutics was a Series D investment on 25 May 2023. The participating investors for this round are not specified. This funding can be assumed to support the company's ongoing research and development efforts, as well as to further advance its mRNA drug projects. Stemirna Therapeutics stands at the forefront of groundbreaking RNA technology within the biotech and pharmaceutical industries. With its clear focus on addressing critical medical needs such as cancer and infectious diseases, the company presents an intriguing investment opportunity within the rapidly evolving landscape of healthcare and life sciences.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• - 25 May 2023
Series C •••••• 10
Investor Investor Investor Investor
•••• •••• 		03 Jun 2021
Series B •••••• 1
Investor
01 Sep 2020
Series A •••••• 2
Investor
•••• •••• 		01 Feb 2020
Series A •••••• 4
Investor Investor
•••• •••• 		12 Aug 2019

View All 7 Funding Rounds

Stemirna Therapeutics Alternatives & Competitors

Stemirna Therapeutics vs
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. Korea South

Pharmaceuticals, focuses on the research and development of mRNA (messenger RNA) vaccines and therap...

6 employees
Health Care, Health and Wellness
Stemirna Therapeutics vs
FUTR BIO
FUTR BIO Brazil

We develop next generation mRNA vaccines to prevent and cure diseases such as infections and cancer.

Pre Seed
3 employees
Biotechnology
Stemirna Therapeutics vs
IMMORNA
IMMORNA United States

Our RNA Encodes Innovation

Series A
20 employees

FAQ About Stemirna Therapeutics

Stemirna Therapeutics is a company centered on RNA technology for drug development, aiming to harness the full potential of RNA science. With a portfolio of more than a dozen independently-developed mRNA drug projects, the company focuses on mRNA-based personalized cancer vaccines, mRNA vaccines for...
Stemirna Therapeutics was founded in 2016.
Stemirna Therapeutics operates in the following industries: Biotechnology, Pharmaceutical.
Stemirna Therapeutics has approximately 4 employees.
Stemirna Therapeutics has completed 7 funding rounds, raising a total of $1.33B. The latest funding stage is Series D.
Top alternatives and competitors to Stemirna Therapeutics include mCureX Therapeutics, Inc., FUTR BIO, IMMORNA, Su Hui therapy, Arcturus Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stemirna Therapeutics and mCureX Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Stemirna Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy